Finance

Lists
Why is 006280 up 2,43%?
Dive Deeper
006280:KRX
GC Biopharma Corp
130 700,00 KRW
+2,43%
(+3 100,00) 1D
19-окт., 15:30:10 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 006280...
Open
127 500 KRW
High
130 900 KRW
Low
126 600 KRW
Mkt. cap
1,53 трлн
Avg. vol.
20,39 миң
Volume
18,16 миң
Dividend
1,15%
Quarterly dividend
375 KRW
Ex-dividend date
2026-ж., 30-мар.
52-wk high
183 800 KRW
52-wk low
105 900 KRW
EPS
-4 372 KRW
Shares outstanding
11,69 млн
No. of employees
2 миң
Open
127 500 KRW
High
130 900 KRW
Low
126 600 KRW
Mkt. cap
1,53 трлн
Avg. vol.
20,39 миң
Volume
18,16 миң
Dividend
1,15%
Quarterly dividend
375 KRW
Ex-dividend date
2026-ж., 30-мар.
52-wk high
183 800 KRW
52-wk low
105 900 KRW
EPS
-4 372 KRW
Shares outstanding
11,69 млн
No. of employees
2 миң
News stories
From web sources and news partners
Profile
GC Biopharma also known as Green Cross Corporation is a biopharmaceutical company headquartered in Yongin, South Korea. Wikipedia
About GC Biopharma Corp
CEOEun Chul Huh | Il-sup Huh
Employees2,11 миң
Founded1967-ж., 5-окт.
Headquarters-
Sector-
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
609,49 млд
497,75 млд
435,53 млд
421,18 млд
Cost of goods sold
463,97 млд
357,85 млд
313,13 млд
312,00 млд
Cost of revenue
463,97 млд
357,85 млд
313,13 млд
312,00 млд
Research and development expenses
33,48 млд
44,81 млд
35,32 млд
38,34 млд
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
77,09 млд
83,01 млд
70,35 млд
65,07 млд
Operating expense
116,30 млд
135,30 млд
110,67 млд
107,45 млд
Total operating expenses
580,27 млд
493,15 млд
423,80 млд
419,45 млд
Operating income
29,21 млд
4,60 млд
11,73 млд
1,73 млд
Other non operating income
13,04 млн
636,32 млн
-10,15 млд
-6,20 млд
EBT including unusual items
24,89 млд
-110,07 млд
28,59 млд
-1,60 млд
EBT excluding unusual items
21,52 млд
-4,39 млд
25,91 млд
-14,17 млд
Income tax expense
6,74 млд
-7,27 млд
8,45 млд
-2,65 млд
Effective tax rate
27,07%
6,61%
29,56%
165,54%
Other operating expenses
296,00 млн
306,00 млн
590,00 млн
308,00 млн
Net income
15,95 млд
-88,30 млд
20,47 млд
1,98 млд
Net profit margin
2,62%
-17,74%
4,70%
0,47%
Earnings per share
1,40 миң
-
1,79 миң
174,00
Interest and investment income
605,00 млн
623,00 млн
881,00 млн
418,00 млн
Interest expense
-12,76 млд
-13,40 млд
-13,27 млд
-11,50 млд
Net interest expenses
-12,15 млд
-12,77 млд
-12,39 млд
-11,08 млд
Depreciation and amortization charges
1,68 млд
2,17 млд
1,63 млд
1,22 млд
EBITDA
50,70 млд
24,79 млд
34,46 млд
22,90 млд
Gain or loss from assets sale
-268,00 млн
1,01 млд
-35,56 млд
38,60 млн
AI content may include mistakes. Learn more
Google колдонмолору